tiprankstipranks
Akero Therapeutics Inc (AKRO)
NASDAQ:AKRO
US Market

Akero Therapeutics (AKRO) Technical Analysis

Compare
554 Followers

Technical Sentiment

Overall Consensus
Buy
12Bullish
5Neutral
5Bearish
Technical Analysis Consensus
Neutral
3Bullish
5Neutral
2Bearish
Moving Average Consensus
Buy
9Bullish
0Neutral
3Bearish
Akero Therapeutics Inc’s (AKRO) Moving Averages Convergence Divergence (MACD) indicator is 2.40, suggesting Akero Therapeutics Inc is a Buy.
Akero Therapeutics Inc’s (AKRO) 20-Day exponential moving average is 48.04, while Akero Therapeutics Inc’s (AKRO) share price is $49.12, making it a Buy.
Akero Therapeutics Inc’s (AKRO) 50-Day exponential moving average is 42.09, while Akero Therapeutics Inc’s (AKRO) share price is $49.12, making it a Buy.

Akero Therapeutics (AKRO) Pivot Points

Mar 03, 2025, 11:16 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
43.58
45.12
46.43
47.97
49.29
50.83
52.14
Fibonacci
45.12
46.21
46.88
47.97
49.06
49.74
50.83
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Akero Therapeutics (AKRO) Moving Averages

Mar 03, 2025, 11:16 AM
Period
Simple
Exponential
MA5
48.31Buy
48.69Buy
MA10
49.46Sell
49.15Sell
MA20
51.27Sell
48.04Buy
MA50
38.69Buy
42.09Buy
MA100
34.71Buy
36.83Buy
MA200
29.66Buy
31.49Buy
Akero Therapeutics Inc’s (AKRO) 10-Day exponential moving average is 49.15, while Akero Therapeutics Inc’s (AKRO) share price is $49.12, making it a Sell.
Akero Therapeutics Inc’s (AKRO) 100-Day exponential moving average is 36.83, while Akero Therapeutics Inc’s (AKRO) share price is $49.12, making it a Buy.
Akero Therapeutics Inc’s (AKRO) stock price is $49.12 and Akero Therapeutics Inc’s (AKRO) 50-day simple moving average is 38.69, creating a Buy signal.
Akero Therapeutics Inc’s (AKRO) stock price is $49.12 and Akero Therapeutics Inc’s (AKRO) 100-day simple moving average is 34.71, creating a Buy signal.
Akero Therapeutics Inc’s (AKRO) stock price is $49.12 and Akero Therapeutics Inc’s (AKRO) 200-day simple moving average is 29.66, creating a Buy signal.

Akero Therapeutics (AKRO) Technical Indicators

Mar 03, 2025, 11:16 AM
Name
Value
Implied Action
RSI (14)
57.10
Neutral
STOCH (9,6)
26.63
Neutral
STOCHRSI (14)
17.27
Buy
MACD (12,26)
2.40
Buy
ADX (14)
32.11
Neutral
Williams %R
-70.42
Buy
CCI (14)
-86.92
Neutral
ATR (14)
2.78
-
Ultimate Oscillator
43.37
Neutral
ROC
-9.39
Sell
Akero Therapeutics Inc’s (AKRO) Relative Strength Index (RSI) is 57.10, creating a Neutral signal.
Akero Therapeutics Inc’s (AKRO) Trend Strength Indicator (ADX) is 32.11, creating a Neutral signal.
Akero Therapeutics Inc’s (AKRO) Commodity Channel Index (CCI) is -86.92, creating a Neutral signal.
Akero Therapeutics Inc’s (AKRO) Price Rate of Change (ROC) is -9.39, creating a Sell signal.

FAQ

Is AKRO a Buy, Hold, or Sell?
Based on AKRO’s technical indicators, AKRO is a Buy.
    What is AKRO’s RSI (14)?
    AKRO’s RSI (14) is 57.10, which suggests AKRO is a Neutral.
      What is AKRO’s MACD?
      AKRO’s MACD is 2.40, which suggests AKRO is a Buy.
        What is AKRO’s 5-day moving average?
        AKRO’s 5-day moving average is 48.31, which suggests AKRO is a Buy.
          What is AKRO’s 20-day moving average?
          AKRO 20-day moving average is 51.27, which suggests AKRO is a Sell.
            What is AKRO’s 50-day moving average?
            AKRO’s 50-day moving average is 38.69, which suggests AKRO is a Buy.
              What is AKRO’s 200-day moving average?
              AKRO’s 200-day moving average is 29.66, which suggests AKRO is a Buy.
                What is AKRO’s Williams % R (14)?
                AKRO’s Williams % R (14) is -70.42, which suggests AKRO is a Buy.
                  What is AKRO’s CCI (14)?
                  AKRO’s CCI (14) is -86.92, which suggests AKRO is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis